Loading...

Financial Summary


GW Pharmaceuticals Plc

GW Pharmaceuticals Plc (GWPH)

Healthcare
Buy
B+
Market Info
Financial Info
Financial Modelling
Symbol GWPH
Price 108.51$
Beta 2.79
Volume Avrg. 0.35M
Market Cap 36.24B
Shares (2018) 333,936.00K
Last Div 0
Dividend Yield -
DCF Unlevered -
DCF Levered -
ROE -71.10% Strong Sell
ROA -71.22% Strong Sell
Operating Margin -2303.34% Strong Sell
Debt / Equity 1.42% Neutral
P/E - Neutral
P/B 11.17 Strong Buy

Income Statement

Download GWPH income statement Download GWPH income statement
Year 2011 2012 2013 2014 2015 2016 2017 2018
Earnings Per Share Basic -------0.04-0.11
Net Profit Margin -------7.20-23.17
Earnings Per Share Diluted -------0.04-0.11
Revenue ------12.7312.74
Weighted Average Shares Outstanding -------366.52
Gross Profit 28.2832.2826.0227.9825.928.914.11-19.80
Weighted Average Shares Outstanding (Diluted) ---177.52177.52236.65272.17333.94
Sales, General and Administrative Expense ------33.19141.82
Dividend per Share --------
Operating Income 2.271.08-10.23-22.83-63.43-128.65-166.16-293.38
Gross Margin ------0.700.53
Earnings before Tax -------92.39-291.37
EBITDA Margin -0.100.06-0.34-0.60-1.92-6.83-22.05
Net Income -------91.70-295.17
EBIT Margin -------7.24-22.78
Net Income - Discounted ops --------
Profit Margin -0.090.07-0.17-0.49-1.56-7.20-23.17
Preferred Dividends --------
Free Cash Flow margin -------0.00-0.00
R&D Expenses ------104.38153.74
Interest Expense 0.000.000.060.060.070.240.95-1.18
Earnings Before Tax Margin -------7.26-22.88
Consolidated Income -------91.70-295.17
EBIT 2.531.24-10.29-19.51-56.99-92.14-170.54-293.38
EBITDA -------86.99-280.83
Income Tax Expense -------0.693.80
Operating Expenses 26.0131.2036.2550.8189.35137.56170.27319.99
Cost of Revenue ------3.825.99
Net Income Com -------91.70-295.17
Net Income - Non-Controlling int --------

Balance Sheet Statement

Download GWPH income statement Download GWPH income statement
Year 2012 2013 2014 2015 2016 2017 2018
Total current liabilities 11.5612.7217.3327.7745.5144.9166.22
Other Liabilities 2.453.18-3.10-4.8139.9437.1555.85
Long-term debt -1.911.781.5410.866.3513.67
Cash and cash equivalents 29.3438.07164.49234.87487.51322.15591.50
Total debt --2.001.911.655.175.91
Cash and short-term investments 29.3438.07164.49234.87487.51322.15591.50
Deferred revenue -12.5812.1012.719.998.04-
Inventories 3.544.664.784.765.535.6733.03
Tax Liabilities ----0.370.881.39
Goodwill and Intangible Assets 5.215.215.215.466.786.96-
Deposit Liabilities -------
Tax assets -0.823.795.5313.0625.207.33
Total non-current liabilities -10.1310.8217.5916.7119.7416.71
Total current assets -7.6411.5817.1334.6148.6699.82
Total liabilities 21.6923.5434.9244.4871.2162.1081.99
Payables 9.119.4420.3032.474.477.769.80
Other comprehensive income -------75.19
Short-term investments -------
Retained earnings (deficit) -65.03-68.97-81.46-123.45-231.56-461.87-828.94
Property, Plant & Equipment Net 2.435.4811.6428.7350.7163.1790.83
Total non-current assets -10.1310.8217.5916.7119.7416.71
Other Assets -----35.3917.90
Net Debt ------315.80-577.26
Investments -------
Total shareholders equity 21.2335.40158.58245.27518.89380.82674.08
Total assets 42.9258.94193.50289.75590.10442.92756.07
Long-term investments -------
Receivables 1.591.731.862.8730.261.374.19
Short-term debt -0.100.130.111.10-0.57

Cash Flow Statement

Download GWPH income statement Download GWPH income statement
Year 2011 2012 2013 2014 2015 2016 2017 2018
Insurance (repayment) of debt --------
Net Cash/Marketcap ------0.000.00
Insurance (buybacks) of shares --------
Depreciation & Amortization ------5.159.29
Dividend payments --------
Operating Cash Flow 2.361.80-7.47-12.63-46.47-119.93-148.97-297.84
Acquisitions and disposals --------
Free Cash Flow -1.470.48-9.71-19.87-64.38-132.84-264.75
Net cash flow / Change in cash -3.111.028.73126.4270.38128.1532.76
Effect of forex changes on cash --0.010.200.031.886.22-13.27-0.24
Financing Cash Flow 1.390.0718.25144.27128.42274.26-1.211,297.87
Investment purchases and sales --------
Capital Expenditure -0.89-1.32-2.24-7.24-17.91-12.91-20.10-74.75
Stock-based compensation -0.801.010.621.242.4812.6631.63
Investing Cash Flow --------

Retained Earning Schedule

Year 2012 2013 2014 2015 2016 2017 2018
Retained Earnings (Previous Year) --65-69-81-123-232-462
Net Income ------92-295
Stock Dividends -65-4-12-42-108-139-72
Divident Paid -------
Retained Earnings -65-69-81-123-232-462-829

PPE Schedule

Year 2012 2013 2014 2015 2016 2017 2018
Year 2012201320142015201620172018
Gross PPE -2512295163
Annual Depreciation 4513353533102
Capital Expenditure -1-2-7-18-13-20-75
Net PPE 251229516391

Intangible and Goodwill Schedule

Year 2012 2013 2014 2015 2016 2017 2018
Intangible and Goodwill (Previous Year) -555577
New Purchases -------
Intangible and Goodwill 555577-
GW Pharmaceuticals Plc

GW Pharmaceuticals Plc (GWPH)

108.51
-2.41 (-2.17%)

About


Justin David Gover
Healthcare
Drug Manufacturers
NASDAQ Global Market

GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.